134 related articles for article (PubMed ID: 10438283)
1. [Reply to comment on Pathologica 1998; 90:357-363].
Bondi A
Pathologica; 1999 Feb; 91(1):63. PubMed ID: 10438283
[No Abstract] [Full Text] [Related]
2. False negative rate in mass screening for cervical cancer.
Sato S; Mikino H; Matsunaga G; Yajima A
Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728
[No Abstract] [Full Text] [Related]
3. [Cytological diagnosis of cancer of the uterine cervix. Results during 1971].
Gerber E; Vajda D
Rev Med Suisse Romande; 1972 Oct; 92(10):813-28. PubMed ID: 4660894
[No Abstract] [Full Text] [Related]
4. [Impulse cytophotometric measurements on atypical cell smears from vagina and cervix uteri].
Göhde W; Dittrich W; Zinser KH; Prieshof J
Geburtshilfe Frauenheilkd; 1972 May; 32(5):382-93. PubMed ID: 4558244
[No Abstract] [Full Text] [Related]
5. [Future aspects of cytology].
Sprenger E; Sandritter W
Med Welt; 1973 Mar; 24(11):391-4. PubMed ID: 4573801
[No Abstract] [Full Text] [Related]
6. Cytology screening--a program that works.
MacLean MA
Can Nurse; 1969 May; 65(5):40-3. PubMed ID: 5769363
[No Abstract] [Full Text] [Related]
7. How should adequacy of liquid-based cytology be defined?
Desai M; Herbert A
Cytopathology; 2006 Aug; 17(4):165-7. PubMed ID: 16879262
[No Abstract] [Full Text] [Related]
8. Mass screening for cancer and precancerous conditions of cervix uteri. A preliminary report.
Messelt OT; Höeg K
Acta Cytol; 1967; 11(1):39-40. PubMed ID: 5230439
[No Abstract] [Full Text] [Related]
9. Mass cervical cancer screening program by irrigation smear in Japan.
Kawashima Y; Ino S; Tashiro K; Tachibana M; Masukawa T
Obstet Gynecol; 1968 Jul; 32(1):17-23. PubMed ID: 5742086
[No Abstract] [Full Text] [Related]
10. Challenges in screening for cancer of the cervix: delivery, technology and evaluation of programs.
Morgan PP
Can Med Assoc J; 1982 Oct; 127(7):571-2. PubMed ID: 7127224
[No Abstract] [Full Text] [Related]
11. [Vaginal-cytological examination. Routine examination of a symptom-free young clientele].
Hastrup J; Rojel K
Ugeskr Laeger; 1968 Feb; 130(6):243-5. PubMed ID: 5676294
[No Abstract] [Full Text] [Related]
12. Screening for cervical cancer. Canadian programmatic guidelines.
Parboosingh J
Can Fam Physician; 1999 Feb; 45():383-93. PubMed ID: 10065312
[No Abstract] [Full Text] [Related]
13. [Results of mass screening for cervical cancer performed at the Centro di Citoistodiagnostica degli Spedali Civili in Brescia].
Gastaldi A; Cavaglieri D; Zorzi M; Arrigoni GA
Ann Ostet Ginecol Med Perinat; 1969 Mar; 91(3):163-81. PubMed ID: 5362491
[No Abstract] [Full Text] [Related]
14. Positive smears in previously screened patients (certain cytologic findings of public health importance).
Liu W
Acta Cytol; 1967; 11(3):193-8. PubMed ID: 5232017
[No Abstract] [Full Text] [Related]
15. Gynaecological mass screening in Finland.
Timonen S
Minerva Ginecol; 1971 Jan; 23(1):7-11. PubMed ID: 5553187
[No Abstract] [Full Text] [Related]
16. Premalignant cervical disease: screening, diagnosis, and management.
Jacobs AJ
Nebr Med J; 1981 Mar; 66(3):59-60. PubMed ID: 7231596
[No Abstract] [Full Text] [Related]
17. [Report of 5 years of activity in the prevention of neoplasms of the uterus in the province of Trieste. Prevention, early diagnosis and therapy].
Spanio P; Segata L; Mastrangelo C
Minerva Ginecol; 1971 Feb; 23(3):119-23. PubMed ID: 5579728
[No Abstract] [Full Text] [Related]
18. [Observations on the use of colpocytology in the diagnosis of uterine cervical neoplasms].
França LC; Velloni M; de Lemos S
Matern Infanc (Sao Paulo); 1965; 24(2):214-22. PubMed ID: 5840316
[No Abstract] [Full Text] [Related]
19. [Gynecological cytodiagnosis with screening (a solution from necessity)].
Janisch H; Kremer H
Zentralbl Gynakol; 1969 Nov; 91(45):1488-90. PubMed ID: 5376960
[No Abstract] [Full Text] [Related]
20. Can we change the way we screen?: the ThinPrep Imaging System.
Dawson AE
Cancer; 2004 Dec; 102(6):340-4. PubMed ID: 15540250
[No Abstract] [Full Text] [Related]
[Next] [New Search]
